Most common supraventricular tachycardia
Most common supraventricular tachycardia Supraventricular tachycardia (SVT) is a term that encompasses several rapid heart rhythm disorders originating above the ventricles, primarily in the atria or the atrioventricular (AV) node. Among these, the most common form is atrioventricular nodal reentrant tachycardia (AVNRT). It is characterized by episodes of rapid heartbeat that can start and stop abruptly, often causing symptoms such as palpitations, dizziness, shortness of breath, or chest discomfort. Understanding AVNRT and other common SVTs is essential for proper diagnosis and management.
AVNRT accounts for approximately 60-70% of all episodes of SVT and predominantly affects young and middle-aged individuals, especially women. It occurs due to a reentrant circuit within or near the AV node, a critical structure that conducts electrical impulses from the atria to the ventricles. In AVNRT, there are typically two pathways within the AV node: a fast pathway and a slow pathway. During an episode, an electrical impulse can loop within these pathways, leading to rapid, repetitive stimulation that causes the heart rate to soar, often reaching 150-250 beats per minute. Most common supraventricular tachycardia
Most common supraventricular tachycardia Patients with AVNRT may experience sudden episodes that last from a few seconds to several hours. Common triggers include stress, caffeine, alcohol, or exercise, although episodes can also occur spontaneously. The symptoms are usually sudden in onset and termination, with some individuals feeling a “racing” sensation in the chest, dizziness, or even fainting in severe cases. Despite its distressing symptoms, AVNRT is generally not life-threatening, but it can significantly impact quality of life if episodes are frequent or severe.
Diagnosis of AVNRT typically involves an electrocardiogram (ECG), which captures the characteristic rapid heart rate during an episode. Sometimes, a Holter monitor or event recorder is used to document the arrhythmia over a longer period. Electrophysiological studies may be conducted in complex or refractory cases to precisely identify the reentrant circuit and guide treatment options. Most common supraventricular tachycardia
Management of AVNRT often begins with acute measures to terminate episodes, such as vagal maneuvers (e.g., bearing down or coughing) that stimulate the vagus nerve and slow conduction through the AV node. If these are ineffective, medications like adenosine are administered; this drug temporarily blocks conduction through the AV node, often restoring normal rhythm rapidly. For ongoing prevention, beta-blockers or calcium channel blockers may be prescribed.
In cases of frequent or debilitating episodes, catheter ablation offers a more definitive solution. This minimally invasive procedure involves threading a catheter into the heart via blood vessels to destroy the abnormal pathway responsible for the reentrant circuit. Ablation has a high success rate and can potentially cure AVNRT, reducing or eliminating the need for medication. Most common supraventricular tachycardia
While AVNRT is the most common form of SVT, other types include atrioventricular reciprocating tachycardia (AVRT), often seen in patients with accessory pathways such as in Wolff-Parkinson-White syndrome, and atrial tachycardia, originating from ectopic foci within the atria. Each type has distinct features and treatment approaches, emphasizing the importance of accurate diagnosis.
In conclusion, AVNRT remains a prevalent cause of supraventricular tachycardia, characterized by sudden episodes of rapid heartbeats due to reentrant conduction within or near the AV node. With proper evaluation and treatment options ranging from medication to catheter ablation, most patients can manage their condition effectively, leading to improved quality of life. Most common supraventricular tachycardia